M. El-Kassas Et Al. , "Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma," Journal of Clinical and Experimental Hepatology , vol.15, no.1, 2025
El-Kassas, M. Et Al. 2025. Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology , vol.15, no.1 .
El-Kassas, M., Othman, H. A., Elbadry, M., Alswat, K., & Yılmaz, Y., (2025). Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology , vol.15, no.1.
El-Kassas, Mohamed Et Al. "Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma," Journal of Clinical and Experimental Hepatology , vol.15, no.1, 2025
El-Kassas, Mohamed Et Al. "Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma." Journal of Clinical and Experimental Hepatology , vol.15, no.1, 2025
El-Kassas, M. Et Al. (2025) . "Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma." Journal of Clinical and Experimental Hepatology , vol.15, no.1.
@article{article, author={Mohamed El-Kassas Et Al. }, title={Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma}, journal={Journal of Clinical and Experimental Hepatology}, year=2025}